| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and Departments of Molecular Genetics [H. I. S., L. W., A. d. B., C. T., M. W., G. L.], Veterinary Biosciences [A. d. B., T. J. R.], and Pediatrics [M. L. R.], and Division of Molecular and Human Genetics, Childrens Research Institute [M. L. R.], The Ohio State University, Columbus, Ohio 43210
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Of the seven known E2F family members, E2F1, E2F2, and E2F3a protein levels oscillate during the cell cycle. The expression of this group of E2Fs peaks late in G1 and coincides with the activation of G1-S-specific genes (3) . Consistent with an important role for these proteins in G1-S progression, their ectopic expression in quiescent cells leads to the activation of E2F target genes and drives cells to enter S phase (4 , 5) . On the basis of these properties, E2F1, E2F2, and E2F3a are thought to function as transcriptional activators. In contrast, the E2F3b, E2F4, and E2F5 genes are expressed throughout the cell cycle, and their protein products can be found in association with Rb and Rb-related proteins in growth-arrested G0 cells (6, 7, 8) . These observations, together with the fact that MEFs deficient for E2F4 and E2F5 are insensitive to a p16INK4A-mediated cell cycle arrest (9) , suggest that this group of E2F factors likely functions as transcriptional repressors important for driving cells into, or keeping them in, a G0-quiescent state.
Roles played by the various E2F family members in development have been studied by mouse knockout models. These models have unraveled important functions for the different E2Fs in the differentiation of multiple tissues and in full viability of the organism but have failed to demonstrate an in vivo role for E2Fs in the control of cell proliferation. E2F1-/- mice are viable but prone to various tumors. These mice show a defect in T-cell differentiation that is apparently because of a reduced capacity of their thymocytes to be appropriately activated to undergo programmed cell death (apoptosis; 10, 11, 12 ). E2F2-/- mice remain largely uncharacterized but are fully viable and do not show obvious developmental phenotypes (this study).4 E2F3-/- mice have reduced viability presumably because of a defect in proliferation in certain cell types, such as fibroblasts (13) . E2F4-/- mice are viable but show defects in differentiation of erythrocytes and the gut epithelium (14 , 15) . The development of E2F5-/- embryos appears normal, but newborn mice develop hydrocephalus because of a choroid plexus defect that results in excessive production of cerebrospinal fluid (16) .
The functional relationship between Rb and E2Fs has also been studied in vivo. A major consequence of disrupting Rb in mice is unscheduled DNA replication and extensive apoptosis in the lens and CNS (17 , 18) . These mice die in mid-gestation because of defects in erythropoietic differentiation and the resulting anemia (17, 18, 19) . Binding and inactivation of Rb by the DNA tumor virus oncogenes large T-antigen and E7 also lead to unscheduled proliferation and apoptosis of lens fiber cells (20 , 21) . The fact that Rb-/-E2F1-/- mice exhibit significantly less apoptosis than Rb-/- mice (22 , 23) demonstrates that E2F1, at least in part, mediates the apoptosis resulting from loss of Rb. Consistent with these findings, overexpression of E2F1 in rat fibroblasts leads to the induction of apoptosis (24 , 25) .
Here, we report the targeted disruption of E2F3 in mice, which leads to ablation of both the E2F3a and E2F3b proteins. Analysis of E2F1-/-, E2F2-/-, and E2F3-/- mice suggests that E2F1, E2F2, and E2F3 have largely redundant functions during early embryonic development but make major individual contributions toward the in vivo phenotypic consequences of Rb deficiency.
| Results |
|---|
|
|
|---|
|
|
|
0.1 for all pairwise comparisons; Fig. 2, B and C
0.1 for all pairwise comparisons; Fig. 2, B and C
-crystallins, were expressed appropriately (data not shown). One interpretation of these data are that under normal circumstances, loss of a single E2F member can be functionally compensated by the other related E2F activities.
E2F3 Makes a Major Contribution toward Proliferation in Rb-/- Embryos.
One major consequence of disrupting the Rb pathway in mice is unscheduled DNA replication in the lens and CNS (20, 21, 22, 23
, 29
, 33)
. During normal differentiation of the lens, the Rb pathway is necessary to maintain the G0 state of the differentiated lens fiber cells. Targeted disruption of components of the Rb regulatory pathway either by the overexpression of cyclins (34)
, inactivation of p57, p27 or Rb itself (29
, 33)
, or inactivation of Rb by the viral oncogenes E7 and T-antigen (20, 21, 22)
results in failure of lens epithelial and fiber cells to exit the cell cycle. Rb is thought to be required in maintaining a G0 state by controlling the activities of E2Fs. On Rb loss, many putative E2F-responsive genes, such as cyclins A, B1, and E and the CDKs cdc2, cdk2, and cdk4, are abnormally up-regulated in lens fiber cells, resulting in increased proliferation (35)
. Considering that E2F1, E2F2, and E2F3 are the three growth-regulated activities capable of interacting specifically with Rb, and not with the other pocket-binding proteins p107 and p130, we sought to determine the relative contributions made by these E2Fs toward the phenotypic consequences of Rb loss. Consistent with previous results, we found that a significant proportion of lens fiber cells in E13.5 Rb-/- embryos was unable to exit the cell cycle, as measured by BrdUrd incorporation (Fig. 3A)
. Analysis of embryos deficient for Rb and each of the three activating E2Fs revealed a partial suppression of the unscheduled proliferation (P < 0.001 for each pairwise comparison). The fact that loss of E2F3 had the most pronounced impact suggests that E2F3 makes the major contribution toward the unscheduled proliferation of Rb-/- lenses (Fig. 3C)
. Moreover, observation of DAPI-stained lenses from Rb-/-E2F3-/- embryos by microscopy revealed a cellular arrangement that more closely resembles the typical "bow arrangement" found in properly differentiated lenses of wt embryos (Fig. 3)
.
|
Although the analysis of wt, Rb-/-, and Rb-/-E2F3-/- embryos revealed no obvious changes in the total percentage of replicating cells of the retina (Fig. 3D)
, we did notice that Rb-/- embryos had increased numbers of BrdUrd-incorporating cells in an area of the retina that normally contains postmitotic neurons (Fig. 3E)
. Loss of E2F1, E2F2, and E2F3 from Rb-/- retinas resulted in a reduction in the number of neuronal retina cells undergoing unscheduled DNA replication.
In the CNS, as in the lens and retina, maintenance of a G0 state in differentiated neurons is also dependent on Rb. Loss of Rb function in the CNS has been shown to result in elevated levels of free E2Fs and E2F target genes and unscheduled DNA replication (36)
. The patterns of expression of E2Fs in the CNS is complex and has been thoroughly described previously (27)
. Although E2F1, E2F2, and E2F3 expression is distributed widely over the brain and spinal cord during early embryonic development, by E12.5, their expression is down-regulated in postmitotic neurons of the intermediate and marginal zone but not in the ventricular zone of the brain. E2F3 is present at low levels in the proliferating cells of the ventricular zone and at higher levels in the differentiated neurons of the intermediate and marginal zones. To determine whether the activating E2Fs can mediate the unscheduled proliferation observed in Rb-/- brain tissues, we analyzed postmitotic neurons in the intermediate zone adjacent to the fourth ventricle of the brain of doubly null Rb/E2F embryos for their ability to replicate DNA. As reported previously (36)
, loss of Rb resulted in increased proliferation of the normally postmitotic neurons (Fig. 4A)
. As in the lens fiber cells, there was a significant reduction in the number of proliferating neurons in Rb-/-E2F1-/-, Rb-/-E2F2-/-, and Rb-/-E2F3-/- embryos (Fig. 4B)
. Although all three activating E2Fs contributed to the unscheduled proliferation induced by loss of Rb, E2F1 and E2F3 made the most pronounced contribution to this phenotype; the percentage of proliferating cells in the intermediate zone of Rb-/-E2F1-/- and Rb-/-E2F3-/- embryos was reduced to levels normally found in wt embryos.
|
0.0006; Figs. 5
0.11 and 0.01, respectively), suggesting that apoptosis in the lens and the retina is mediated specifically through E2F1 (Fig. 5)
|
|
| Discussion |
|---|
|
|
|---|
Of the seven known E2F family members, the expression of E2F1, E2F2, and E2F3 is cell cycle regulated, with their levels peaking at the G1-S transition. The oscillating nature of their DNA binding activities during the cell cycle exactly coincides with the expression of known E2F target genes whose protein products are thought to be essential for entry into S phase. Moreover, the ectopic expression of these E2Fs can efficiently induce S phase entry in otherwise quiescent fibroblasts. A series of recent experiments have suggested that there is specificity in promoter occupancy by different E2Fs (40)
and in the target genes that are transcriptionally regulated by E2F1, E2F2, and E2F3 (41
, 42)
. In view of these findings suggesting a critical role for E2Fs in cell growth control, it is surprising that E2F1-/- and E2F2-/- MEFs have no measurable growth defect and that E2F3-/- MEFs have only a mild defect (13
, 26)
. Additionally, the disruption of E2F1, E2F2, or E2F3 in mice does not significantly affect cellular proliferation in the developing lens, retina, or CNS, tissues known to undergo unregulated proliferation on disruption of Rb. Neither do their loss significantly alter the localization or levels of the late stage lens differentiation markers,
- or ß-crystallins (data not shown). This is consistent with the lack of an overall change in the appearance and cellularity of E13.5 E2F mutant embryos (Figs. 1
and 2
and data not shown). One interpretation of these data are that under normal circumstances, loss of a single E2F member can be functionally compensated by other related E2F activities. This notion of functional redundancy among E2Fs is substantiated by our recent findings, indicating that E2F1-/-E2F3-/- and E2F2-/-E2F3-/- embryos are early embryonic lethal and that MEFs lacking all three E2Fs (conditionally deleted via Cre-mediated recombination) have a severe growth defect (43)
. It will be important to determine whether ablation of multiple E2Fs from selected tissues, such as the lens, affects proliferation and differentiation in vivo.
In contrast to the lack of a strict requirement for individual E2F activities in the control of proliferation during normal embryonic development, we show that E2F1, E2F2, and E2F3 can make major contributions toward the phenotypic consequences of Rb deficiency (Figs. 3
4
5
6)
. Each of these E2F family members contributes toward the inappropriate proliferation of Rb-/- lens fiber cells and neurons of the CNS and the retina, with E2F3 making the most profound contribution to this phenotype in the lens (Figs. 3, A and C
and 4, A and B
). Whether E2F3 can mediate the unscheduled proliferation and/or apoptosis observed in Rb-/- embryos through E2F3a, E2F3b, or both remains to be determined. Perhaps most dramatic is the almost complete abolishment of apoptosis in the CNS, lens, and retina of Rb-/-E2F1-/- and in the CNS of Rb-/-E2F3-/- embryos (Figs. 5
and 6
), suggesting important roles for E2F1 and E2F3 in the control of apoptosis. It appears that loss of the regulation imposed by Rb causes E2F function to become unchecked, leading to greatly exaggerated biological consequences, not unlike the unscheduled proliferation and/or apoptosis observed when these E2Fs are overexpressed in fibroblasts and in lens fiber cells (44)
. Our present results provide striking in vivo evidence that E2F1, E2F2, and E2F3 are important effectors of Rb function that must be kept under constant control for the maintenance of a postmitotic state.
Specificity of function for E2Fs can also be inferred from the present studies. Previous work demonstrated that E2F1 can in part mediate the apoptosis and proliferation induced by loss of Rb (22
, 23)
. The work described here illustrates that there is specificity of function among E2Fs in mediating proliferation and apoptosis in vivo. Although the apoptosis arising in Rb-/- lenses and retinas is uniquely mediated by E2F1, all three E2Fs contribute to the control of proliferation in cells of these tissues (Fig. 3)
. These findings are consistent with the previous observation that overexpression of E2F1, but not E2F25, can induce apoptosis in serum-starved rat fibroblasts and with recent findings linking E2F1, but not E2F2 or E2F3, in Myc-induced apoptosis of primary MEFs (4
, 26)
. These results strongly suggest that, at least in the developing lens, apoptosis is not simply a consequence of the unscheduled proliferation resulting from the inactivation of Rb but likely reflects a specific signal mediated by E2F1. Our observations that E2F1 and E2F3, but not E2F2, are required to elicit an apoptotic signal in the CNS of Rb-/- embryos substantiates the concept of specificity among E2Fs. Clearly, E2F2, which has an identical spatial and temporal expression profile as E2F1 in the CNS and the retina (45)
, is not without an effect in these tissues, as its loss significantly reduces the amount of proliferation occurring in postmitotic Rb-/- CNS and retinal neurons.
The unique ability of E2F1 to elicit an apoptotic response in the developing lens and retina of Rb-/- embryos likely reflects its ability to regulate a specific set of target genes. Some evidence for specific gene target activation by E2Fs exists. The overexpression of the various E2Fs in rat embryo fibroblasts can lead to the activation distinct sets of genes (4) . In these cells, E2F1, but not E2F2, can lead to the stabilization of p53 protein and apoptosis (46) . In mouse embryo fibroblasts, the specific induction of the proapoptotic Apaf1 gene by E2F1 is required for the efficient execution of an apoptotic response (47) , providing a further molecular basis for the unique function of E2F1 in apoptosis.
The accumulation of E2F1 is part of the normal cascade of events that occur during the stimulation of cellular proliferation. Several observations may help explain why cells induced to proliferate normally escape from E2F1-mediated cell death. In G0 cells stimulated to reenter the cell cycle, E2F1 DNA binding activity accumulates sharply at the G1-S boundary, quickly decreases as cells progress through S phase, and remains low thereafter during cycling conditions (3) . Thus, E2F1 activity in normal cells is tightly regulated and apparent only at specific points during the cell cycle. On the other hand, in the absence of Rb, E2F1 DNA binding activity accumulates to higher levels than normally found during G1-S and persists throughout the cell cycle. Such unregulated E2F activity might lead to the inappropriate persistent activation of target genes or to the activation of targets normally not activated during G1-S and the ensuing catastrophic consequence of apoptosis. Furthermore, the accumulation of E2F1 during a mitogenic response normally occurs in conjunction with the parallel activation of survival signals, such as those mediated by the phosphatidylinositol 3'-kinase/Akt pathway, allowing cells to proliferate and escape an apoptotic fate. Indeed, the apoptosis resulting from the overexpression of E2F1 in quiescent fibroblasts can be largely abrogated by the addition of serum.4 Thus, E2F1-mediated apoptotic signals could be viewed to represent a checkpoint for proper cell cycle exit/entry that must be negated by either direct binding to Rb or countered by the activation of appropriate survival signals.
Why does the loss of E2F3 rescue the apoptosis occurring in the CNS but not in the lens of Rb-/- embryos? Previous work using chimeric mice reconstituted from Rb+/+ and Rb-/- embryonic stem cells suggested that although Rbs function in the developing lens appears to be cell autonomous, its function in the CNS may be cell nonautonomous (37 , 48) . More recent studies of the developing CNS have defined a role for Rb in the suppression of apoptosis that is cell nonautonomous and a role for suppression of ectopic S phase that is cell autonomous (48) . These findings raise the distinct possibility that suppression of apoptosis in the CNS of Rb/E2F3 double mutant embryos is a cell nonautonomous consequence. Hence, the developing lens may be a uniquely suited tissue in which to investigate the roles for E2Fs in the regulation of apoptosis and cell proliferation without confounding cell extrinsic effects. The replacement of specific E2Fs by other family members using knock-in strategies in vivo might provide more definitive answers to this important issue of functional specificity among E2F family members.
Alternatively, our observation that loss of E2F3 eliminates most of the apoptosis occurring in the CNS, but not in the lens and retina of Rb-/- embryos, might imply that the induction of E2F-mediated apoptosis can be influenced by tissue-specific factors. Considering the complexity of the organization of gene promoters, it is not difficult to envision how additional tissue-specific transcription factors or coactivators might impact, by interacting directly or indirectly with specific E2Fs, on the regulation of E2F target genes responsible for mediating apoptosis, e.g., a putative CNS-specific factor might, by specifically interacting with E2F3, shift its gene target spectrum to include apoptotic-type target genes.
Our finding that E2F1 is the only activating E2F that can mediate apoptosis in the lens and retina is in conflict with a recent report showing a dramatic reduction in apoptosis in the lenses of Rb-/-E2F3-/- mice (49) . Although the genetic background of our studies is similar (C57BL/6 x 129/Sv), these differences might be because of the degree of inbreeding between our strains. In this regard, genetic modifiers have been evoked to explain differences in the severity of growth characteristics of cells lacking E2F3 (13) and might explain the differences observed in the lens.
Finally, we believe that the results presented here directly impact on our understanding and possible development of therapeutic treatments of cancer. Although in normal cells, loss of a single E2F member will likely have no effect on the control of cellular proliferation, under oncogenic circumstances, where the Rb pathway is disrupted, loss of an individual E2F activity may have profound consequences on the fate of the malignant cell. We speculate that targeting the disruption of a single E2F member in human cancers may have either a positive or negative outcome, depending on the tissue origin of the tumor and the ability of the E2F to affect proliferation and/or apoptosis in that tissue.
| Materials and Methods |
|---|
|
|
|---|
BrdUrd Incorporation and TUNEL Assays.
BrdUrd assays were performed as described previously (21)
. Pregnant mice (13.515.5 days postcoitum) were injected i.p. with BrdUrd (100 µg/grams body weight) 2 h before sacrificing, and individual embryos were fixed in formalin. We analyzed at least three embryos of each genotype that were derived from at least two different litters (i.e., two different mothers). Sections (5 µm) were deparaffinized, rehydrated, digested with pepsin, and denatured in HCl. BrdUrd incorporation was detected using an anti-BrdUrd antibody (DAKO Co.) and a secondary FITC-antimouse monoclonal antibody (Vector Laboratories). Nuclei were counterstained with DAPI.
The TUNEL/peroxidase assay was done according to the manufacturers instructions (Invitrogen), except that cells were treated with 0.1% Triton X-100 for 10 min before proteinase K digestion, and the terminal deoxynucleotidyltransferase reaction was performed for 1.5 h. Nuclei were counterstained with DAPI. The percentage of apoptotic or proliferating cells was calculated by counting the total number of BrdUrd- or TUNEL-positive cells relative to the number of DAPI-stained cells. Approximately 150 epithelial cells, 300 fiber cells, and 300 neuronal cells from the retina were counted from each lens section. Approximately 400 cells from the intermediate zone adjacent to the fourth ventricle were analyzed per brain section. In each case, at least four sections per embryo were analyzed. The lens epithelial cells were also analyzed as described (31
, 32)
. Briefly, the lens was divided into equal quarters, and two of the quarters were divided using a protractor into 10-degree sections that ranged from -20° to 90°. Cells were counted from the -20° area, which corresponds to 20° beyond the lens equator, facing the retina, to the 90° position, which corresponds to the middle of the epithelial cell layer facing the cornea (Fig. 2A)
. Statistical analysis was performed by the two-tailed, unequal variance paired t test using the Microsoft Excel program.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Supported by grants from the National Eye Institute (RO1EY12995; to M. L. R.) and the National Cancer Institute (RO1CA82259 and RO1CA85619; to G. L.). H. I. S. was supported by an National Cancer Institute minority postdoctoral supplement; a NIH T-32 award supported L. W. C. T. was supported by an ACS Postdoctoral Fellowship, and G. L. is a V-Foundation and Pew scholar. ![]()
2 To whom requests for reprints should be addressed, at Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and Department of Molecular Genetics 620 MRF 420 12th Avenue, Columbus, Ohio 43210. Phone: (614) 688-4567; Fax: (614) 688-4245; E-mail: Leone-1{at}medctr.osu.edu ![]()
3 The abbreviations used are: CDK, cyclin-dependent kinase; CNS, central nervous system; DAPI, 4',6-diamidino-2-phenylindole; MEF, mouse embryonic fibroblast; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end labeling; wt, wild type; Rb, retinoblastoma. ![]()
5 S. Field, personal communication. ![]()
Received for publication 3/ 4/02. Revision received 4/29/02. Accepted for publication 4/29/02.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J.-L. Chong, S.-Y. Tsai, N. Sharma, R. Opavsky, R. Price, L. Wu, S. A. Fernandez, and G. Leone E2f3a and E2f3b Contribute to the Control of Cell Proliferation and Mouse Development Mol. Cell. Biol., January 15, 2009; 29(2): 414 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rajagopal, L. K. Dattilo, V. Kaartinen, C.-X. Deng, L. Umans, A. Zwijsen, A. B. Roberts, E. P. Bottinger, and D. C. Beebe Functions of the Type 1 BMP Receptor Acvr1 (Alk2) in Lens Development: Cell Proliferation, Terminal Differentiation, and Survival Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4953 - 4960. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. T. Mihaylova, A. M. Green, M. Khurgel, O. J. Semmes, and G. M. Kupfer Human T-Cell Leukemia Virus I Tax Protein Sensitizes p53-Mutant Cells to DNA Damage Cancer Res., June 15, 2008; 68(12): 4843 - 4852. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Angelis, A. Garcia, S. S. Chan, K. Schenke-Layland, S. Ren, S. J. Goodfellow, M. C. Jordan, K. P. Roos, R. J. White, and W. R. MacLellan A Cyclin D2-Rb Pathway Regulates Cardiac Myocyte Size and RNA Polymerase III After Biomechanical Stress in Adult Myocardium Circ. Res., May 23, 2008; 102(10): 1222 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dirlam, B. T. Spike, and K. F. Macleod Deregulated E2f-2 Underlies Cell Cycle and Maturation Defects in Retinoblastoma Null Erythroblasts Mol. Cell. Biol., December 15, 2007; 27(24): 8713 - 8728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Giangrande, J. Zhang, A. Tanner, A. D. Eckhart, R. E. Rempel, E. R. Andrechek, J. M. Layzer, J. R. Keys, P.-O. Hagen, J. R. Nevins, et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia PNAS, August 7, 2007; 104(32): 12988 - 12993. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McClellan, V. A. Ruzhynsky, D. N. Douda, J. L. Vanderluit, K. L. Ferguson, D. Chen, R. Bremner, D. S. Park, G. Leone, and R. S. Slack Unique Requirement for Rb/E2F3 in Neuronal Migration: Evidence for Cell Cycle-Independent Functions Mol. Cell. Biol., July 1, 2007; 27(13): 4825 - 4843. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ahuja, P. Sdek, and W. R. MacLellan Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration Physiol Rev, April 1, 2007; 87(2): 521 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Parisi, T. L. Yuan, A. M. Faust, A. M. Caron, R. Bronson, and J. A. Lees Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues Mol. Cell. Biol., March 15, 2007; 27(6): 2283 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Wenzel, L. Wu, A. de Bruin, J.-L. Chong, W.-Y. Chen, G. Dureska, E. Sites, T. Pan, A. Sharma, K. Huang, et al. Rb is critical in a mammalian tissue stem cell population Genes & Dev., January 1, 2007; 21(1): 85 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gu, R. P. Singh, S. Dhanalakshmi, S. Mohan, and R. Agarwal Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice. Mol. Cancer Ther., August 1, 2006; 5(8): 2121 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Qin, R. Kishore, C. M. Dolan, M. Silver, A. Wecker, C. N. Luedemann, T. Thorne, A. Hanley, C. Curry, L. Heyd, et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF PNAS, July 18, 2006; 103(29): 11015 - 11020. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Hallstrom and J. R. Nevins Jab1 is a specificity factor for E2F1-induced apoptosis Genes & Dev., March 1, 2006; 20(5): 613 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, Y. Chang, B. Schweers, M. A. Dyer, X. Zhang, S. W. Hayward, and D. W. Goodrich An E2F Binding-Deficient Rb1 Protein Partially Rescues Developmental Defects Associated with Rb1 Nullizygosity Mol. Cell. Biol., February 15, 2006; 26(4): 1527 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Takahashi, B. Contreras, R. T. Bronson, M. Loda, and M. E. Ewen Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression Mol. Cell. Biol., December 1, 2004; 24(23): 10406 - 10415. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ziebold, E. Y. Lee, R. T. Bronson, and J. A. Lees E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas Mol. Cell. Biol., September 15, 2003; 23(18): 6542 - 6552. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. X. Li, J. W. Zhu, C. J. Hogan, and J. DeGregori Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice Mol. Cell. Biol., May 15, 2003; 23(10): 3607 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. MUNDLE and G. SABERWAL Evolving intricacies and implications of E2F1 regulation FASEB J, April 1, 2003; 17(6): 569 - 574. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |